Market Cap 23.93M
Revenue (ttm) 600,000.00
Net Income (ttm) -75.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -12,506.67%
Debt to Equity Ratio -16.18
Volume 153,300
Avg Vol 67,686
Day's Range N/A - N/A
Shares Out 21.18M
Stochastic %K 78%
Beta 0.12
Analysts Strong Sell
Price Target $4.00

Company Profile

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-fie...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 348 1188
Address:
26051 Merit Circle, Suite 102, Laguna Hills, United States
SearchFor911
SearchFor911 Mar. 21 at 8:26 AM
$ADGM heading for those 1,7x warrants with data publishing at the end of April. Company will be bought out by one of the big players in 2026/2027 (if data is good).
0 · Reply
lecorb
lecorb Mar. 20 at 12:00 AM
1 · Reply
Rafa007
Rafa007 Mar. 16 at 2:13 PM
$ADGM 🐢
0 · Reply
Hdheheh
Hdheheh Mar. 13 at 5:33 PM
$ADGM I am right once again! No one on this board can ever doubt me!!!!!!
0 · Reply
Rafa007
Rafa007 Mar. 13 at 10:55 AM
$ADGM 🐢
0 · Reply
B2iDigital
B2iDigital Mar. 10 at 1:26 AM
As Marketing Partner for the 38th Annual ROTH Capital Partners Conference, B2i Digital is spotlighting presenting company Adagio Medical Inc. (NASDAQ: $ADGM). Adagio Medical is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. ULTA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLAS™ catheter, which is CE Marked and is currently under evaluation in the FULCRUM-VT U.S. IDE Pivotal Study. FULCRUM-VT, which took only eleven months to fully enroll 209 patients, completed enrollment in October 2025 and FDA approval of vCLAS is expected by the end of 2026. Presenting company website: http://adagiomedical.com/ B2i Digital Featured Conference details: https://b2idigital.com/38th-annual-roth-conference The 38th Annual ROTH Conference is an invitation-only corporate access event connecting executive teams from roughly 500 growth companies with institutional investors and other market participants. The conference is held at The Ritz-Carlton Laguna Niguel in Dana Point, California, March 22 to 24, 2026. It is one of the largest small-cap investor conferences in the United States. Conference features include: • 1-on-1 and small group management-investor meetings • Analyst-selected fireside chats, industry keynotes, and panels • ROTH Consumer Private Company Day & Emerging Brand Showcase • Inaugural Engineering & Construction Day (NEW) • ROTH/CAF Charity Ride, Spin, Yoga, Pickleball & Golf (Sunday) • Networking receptions and live evening entertainment B2i Digital, The Capital Markets Matchmaker℠, will leverage its network of 1.5 million+ investors to help enhance visibility for presenting companies, aligned with our mantra, From Marketing to Meetings℠. Registration is required and subject to approval by ROTH: https://www.meetmax.com/sched/event_127123/conference_home.html Credit to the team at ROTH for hosting this premier event: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia "Charo" Montano, Grace Deller, Amanda McAdams, Adam Walsh, MD, MBA, Jason Wittes, Boobalan Pachaiyappan, Ph.D. Jonathan Aschoff, Ph.D., Harry Fong, James Antonopoulos, Benjamin Bowen, Kris S., Keith Wellen, Andrew Kellogg, Matt Robinson, CPA David Shapiro and Joseph Azizo from B2i Digital will also be in attendance and look forward to seeing you there. ROTH is a relationship-driven investment bank focused on serving growth companies and their investors across capital raising, equity research, sales and trading, M&A advisory, and corporate access. B2i Digital is not a broker-dealer or investment adviser. This is for general information only and is not an offer to buy or sell any security.
1 · Reply
bigmoney_nowhammies
bigmoney_nowhammies Mar. 9 at 12:20 PM
$ADGM https://investors.adagiomedical.com/node/7876/html
0 · Reply
aly2006g
aly2006g Mar. 5 at 2:09 PM
0 · Reply
Hdheheh
Hdheheh Mar. 5 at 2:30 AM
$ADGM this will squeeze soon, yes I am confident, yes I will be right because I know the market better than you!
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 5:11 PM
$ADGM RSI: 45.37, MACD: 0.0057 Vol: 0.02, MA20: 1.00, MA50: 0.99 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on ADGM
Adagio Medical Reports Third Quarter 2025 Results

Nov 12, 2025, 4:05 PM EST - 4 months ago

Adagio Medical Reports Third Quarter 2025 Results


Adagio Medical Reports Second Quarter 2025 Results

Aug 13, 2025, 4:30 PM EDT - 7 months ago

Adagio Medical Reports Second Quarter 2025 Results


Adagio Medical Reports First Quarter 2025 Results

May 15, 2025, 4:05 PM EDT - 11 months ago

Adagio Medical Reports First Quarter 2025 Results


Adagio Medical Provides Clinical and Business Updates

Mar 17, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Clinical and Business Updates


Adagio Medical Reports Third Quarter 2024 Results

Nov 14, 2024, 4:01 PM EST - 1 year ago

Adagio Medical Reports Third Quarter 2024 Results


Adagio Medical Provides Business Updates

Aug 19, 2024, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Business Updates


SearchFor911
SearchFor911 Mar. 21 at 8:26 AM
$ADGM heading for those 1,7x warrants with data publishing at the end of April. Company will be bought out by one of the big players in 2026/2027 (if data is good).
0 · Reply
lecorb
lecorb Mar. 20 at 12:00 AM
1 · Reply
Rafa007
Rafa007 Mar. 16 at 2:13 PM
$ADGM 🐢
0 · Reply
Hdheheh
Hdheheh Mar. 13 at 5:33 PM
$ADGM I am right once again! No one on this board can ever doubt me!!!!!!
0 · Reply
Rafa007
Rafa007 Mar. 13 at 10:55 AM
$ADGM 🐢
0 · Reply
B2iDigital
B2iDigital Mar. 10 at 1:26 AM
As Marketing Partner for the 38th Annual ROTH Capital Partners Conference, B2i Digital is spotlighting presenting company Adagio Medical Inc. (NASDAQ: $ADGM). Adagio Medical is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. ULTA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The Company is currently focused on the treatment of ventricular tachycardia (VT) with its purpose-built vCLAS™ catheter, which is CE Marked and is currently under evaluation in the FULCRUM-VT U.S. IDE Pivotal Study. FULCRUM-VT, which took only eleven months to fully enroll 209 patients, completed enrollment in October 2025 and FDA approval of vCLAS is expected by the end of 2026. Presenting company website: http://adagiomedical.com/ B2i Digital Featured Conference details: https://b2idigital.com/38th-annual-roth-conference The 38th Annual ROTH Conference is an invitation-only corporate access event connecting executive teams from roughly 500 growth companies with institutional investors and other market participants. The conference is held at The Ritz-Carlton Laguna Niguel in Dana Point, California, March 22 to 24, 2026. It is one of the largest small-cap investor conferences in the United States. Conference features include: • 1-on-1 and small group management-investor meetings • Analyst-selected fireside chats, industry keynotes, and panels • ROTH Consumer Private Company Day & Emerging Brand Showcase • Inaugural Engineering & Construction Day (NEW) • ROTH/CAF Charity Ride, Spin, Yoga, Pickleball & Golf (Sunday) • Networking receptions and live evening entertainment B2i Digital, The Capital Markets Matchmaker℠, will leverage its network of 1.5 million+ investors to help enhance visibility for presenting companies, aligned with our mantra, From Marketing to Meetings℠. Registration is required and subject to approval by ROTH: https://www.meetmax.com/sched/event_127123/conference_home.html Credit to the team at ROTH for hosting this premier event: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia "Charo" Montano, Grace Deller, Amanda McAdams, Adam Walsh, MD, MBA, Jason Wittes, Boobalan Pachaiyappan, Ph.D. Jonathan Aschoff, Ph.D., Harry Fong, James Antonopoulos, Benjamin Bowen, Kris S., Keith Wellen, Andrew Kellogg, Matt Robinson, CPA David Shapiro and Joseph Azizo from B2i Digital will also be in attendance and look forward to seeing you there. ROTH is a relationship-driven investment bank focused on serving growth companies and their investors across capital raising, equity research, sales and trading, M&A advisory, and corporate access. B2i Digital is not a broker-dealer or investment adviser. This is for general information only and is not an offer to buy or sell any security.
1 · Reply
bigmoney_nowhammies
bigmoney_nowhammies Mar. 9 at 12:20 PM
$ADGM https://investors.adagiomedical.com/node/7876/html
0 · Reply
aly2006g
aly2006g Mar. 5 at 2:09 PM
0 · Reply
Hdheheh
Hdheheh Mar. 5 at 2:30 AM
$ADGM this will squeeze soon, yes I am confident, yes I will be right because I know the market better than you!
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 3 at 5:11 PM
$ADGM RSI: 45.37, MACD: 0.0057 Vol: 0.02, MA20: 1.00, MA50: 0.99 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Rafa007
Rafa007 Feb. 26 at 3:13 PM
$ADGM cmonn. ....baby
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 4:16 PM
$ADGM Current Stock Price: $0.99
0 · Reply
RegulatoryPro
RegulatoryPro Feb. 18 at 4:26 PM
$ADGM Adagio Medical develops arrhythmia treatment technologies. Adoption depends on clinical outcomes and physician acceptance. Capital intensity increases risk.
0 · Reply
MarketArchetypes
MarketArchetypes Feb. 17 at 1:20 PM
$ADGM Obscure micro-cap; minimal coverage.
0 · Reply
ChartKev21
ChartKev21 Feb. 17 at 8:48 AM
$ADGM Obscure micro-cap; minimal information
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 14 at 12:35 AM
$ADGM Current Stock Price: $0.99
0 · Reply
topstockalerts
topstockalerts Feb. 10 at 1:57 PM
Pre Market Top Gainers PT2 $ESOA $ADGM $SPOG $OSCG $JZXN
0 · Reply
PulseProfits
PulseProfits Feb. 9 at 3:29 PM
$ADGM Advanced manufacturing or genomics; early-stage, unproven business.
1 · Reply
PLX_BULLS
PLX_BULLS Feb. 8 at 5:19 PM
$ADGM nice… https://seekingalpha.com/pr/20387468-new-adagio-medical-publication-highlights-consistent-safety-and-effectiveness-with-ultralow?share_source=shared_news
0 · Reply
87trades
87trades Feb. 5 at 1:37 AM
$ADGM good EFS results and CE mark already secured derisks this a lot.
0 · Reply